ROSEMARY TRITSCHLER: Open Payments
NPI 1265296537 · MONROEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 40 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $414 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 10 | $226 |
| ABBVIE INC. | 14 | $216 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $99 |
| Alkermes, Inc. | 3 | $72 |
| Braeburn Inc. | 3 | $53 |
| Orexo US, Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
Products named: SUBLOCADE, VRAYLAR, CAPLYTA, VIVITROL, BRIXADI, ABILIFY MAINTENA, INGREZZA.
Industry payments across PA — which companies pay providers there.
